Company Biotie Therapies Corp OTC Markets
Equities
BIOZF
FI0009011571
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Antero Kallio
CEO | Chief Executive Officer | 64 | 05-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Cohen
CHM | Chairman | 68 | 16-04-30 |
Jane Wasman
BRD | Director/Board Member | 67 | 16-04-30 |
Andrew Hindman
BRD | Director/Board Member | 51 | 16-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 983,519,747 | 306,896,911 ( 31.20 %) | 2,597,952 ( 0.2641 %) | 31.20 % |
Company contact information
Biotie Therapies Oy
Uudenmaankatu 1-5
00120, Helsinki
+
Sector
1st Jan change | Capi. | |
---|---|---|
+4.83% | 111B | |
+11.22% | 105B | |
-12.41% | 22.34B | |
-3.81% | 21.93B | |
-5.94% | 18.59B | |
-36.52% | 18.12B | |
-9.96% | 16.96B | |
+2.79% | 13.7B | |
+36.03% | 12.45B |
- Stock Market
- Equities
- BTH1V Stock
- BIOZF Stock
- Company Biotie Therapies Corp